menu ☰
menu ˟

Polymyxin B hemoperfusion fails to improve survival in septic shock

10 Oct 2018
Polymyxin B hemoperfusion treatment plus conventional medical therapy was not effective in reducing mortality at 28 days among patients with septic shock and high endotoxin activity, according to research published in JAMA.“Polymyxin B hemoperfusio...

Click here to view the full article which appeared in Infectious Disease

IPH Logo